What is the management for a clonidine (alpha-2 adrenergic agonist) overdose after ingesting 90 tablets of 0.3mg each?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Management of a clonidine overdose of 90 tablets (0.3mg each, totaling 27mg) requires immediate emergency medical attention, with a focus on stabilizing vital signs and addressing potential hypotension and bradycardia. Treatment should begin with the administration of intravenous fluids, such as normal saline, to support blood pressure. For severe hypotension, vasopressors like norepinephrine (starting at 0.1-0.5 mcg/kg/min) or phenylephrine (0.5-1.0 mcg/kg/min) may be necessary 1. Atropine (0.5-1mg IV) can be used for significant bradycardia.

Key considerations in the management of clonidine overdose include:

  • Stabilization of vital signs
  • Administration of intravenous fluids to support blood pressure
  • Use of vasopressors for severe hypotension
  • Use of atropine for significant bradycardia
  • Consideration of activated charcoal (1g/kg) if the patient presents within 1-2 hours of ingestion and has a protected airway
  • Continuous cardiac monitoring due to the risk of arrhythmias and QT prolongation
  • Potential need for intubation and mechanical ventilation in cases of respiratory depression

It's essential to note that clonidine overdose can lead to overstimulation of alpha-2 adrenergic receptors, resulting in decreased sympathetic outflow from the central nervous system, which manifests as hypotension, bradycardia, respiratory depression, miosis, and altered mental status 1. The primary goal of treatment is to support the patient's vital functions until the drug is eliminated, which typically occurs within 24-48 hours. Naloxone may not be effective in reversing the effects of clonidine overdose, as it does not act on alpha-2 adrenergic receptors, but it may be considered in cases where there is suspicion of polysubstance exposure, as seen in the context of opioid-xylazine overdose 1. However, the management of clonidine overdose remains largely supportive and focused on addressing the symptoms and preventing further complications.

From the FDA Drug Label

OVERDOSAGE Hypertension may develop early and may be followed by hypotension, bradycardia, respiratory depression, hypothermia, drowsiness, decreased or absent reflexes, weakness, irritability and miosis. The frequency of CNS depression may be higher in children than adults. Large overdoses may result in reversible cardiac conduction defects or dysrhythmias, apnea, coma and seizures Signs and symptoms of overdose generally occur within 30 minutes to two hours after exposure. As little as 0. 1 mg of clonidine has produced signs of toxicity in children. There is no specific antidote for clonidine overdosage. Clonidine overdosage may result in the rapid development of CNS depression; therefore, induction of vomiting with ipecac syrup is not recommended. Gastric lavage may be indicated following recent and/or large ingestions Administration of activated charcoal and/or a cathartic may be beneficial. Supportive care may include atropine sulfate for bradycardia, intravenous fluids and/or vasopressor agents for hypotension and vasodilators for hypertension Naloxone may be a useful adjunct for the management of clonidine-induced respiratory depression, hypotension and/or coma; blood pressure should be monitored since the administration of naloxone has occasionally resulted in paradoxical hypertension. The management of clonidine overdose involves:

  • Supportive care: monitoring of vital signs and management of symptoms
  • Gastric lavage: may be indicated following recent and/or large ingestions
  • Administration of activated charcoal and/or a cathartic: may be beneficial
  • Atropine sulfate: for bradycardia
  • Intravenous fluids and/or vasopressor agents: for hypotension
  • Vasodilators: for hypertension
  • Naloxone: may be a useful adjunct for the management of clonidine-induced respiratory depression, hypotension and/or coma 2

From the Research

Management of Clonidine Overdose

The management of clonidine overdose involves close attention to vital signs and judicious treatment of specific physiologic abnormalities 3. In the case of a patient who ingested 90 tablets of 0.3mg each, the following management strategies may be considered:

  • Supportive care: Close monitoring of vital signs, including blood pressure, heart rate, and respiratory rate, is essential in managing clonidine overdose 3, 4.
  • Treatment of bradycardia: Atropine may be effective in correcting bradycardia, as seen in a study where atropine was used to treat bradycardia in a pediatric patient with clonidine overdose 3, 4.
  • Management of hypotension: Volume expansion and, if necessary, a continuous infusion of dopamine may be used to manage hypotension 3.
  • Use of naloxone: Naloxone may be of both diagnostic and therapeutic value in treating clonidine overdosage, particularly in pediatric patients 3, 5. However, its effectiveness in adults is less clear, with one study suggesting that it may not be associated with improved outcomes 6.
  • Consideration of compounding errors: In cases where clonidine is compounded as a liquid formulation, there is a risk of dosing errors, which can lead to toxicity 4, 7.

Clinical Effects of Clonidine Overdose

Clonidine overdose can cause a range of clinical effects, including:

  • Sedation and CNS depression: Clonidine overdose can cause sedation, CNS depression, and respiratory depression 3, 4, 6.
  • Bradycardia and hypotension: Clonidine overdose can cause bradycardia and hypotension, which can be managed with atropine and volume expansion, respectively 3, 4.
  • Miosis: Clonidine overdose can cause miosis, which is a characteristic sign of alpha-2 adrenergic agonist toxicity 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Management of clonidine ingestion in children.

The Journal of pediatrics, 1983

Research

Naloxone reversal of clonidine toxicity: dose, dose, dose.

Clinical toxicology (Philadelphia, Pa.), 2018

Research

Toxicity from a clonidine suspension.

Journal of medical toxicology : official journal of the American College of Medical Toxicology, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.